{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T12:04:47Z","timestamp":1782907487685,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000},"content-version":"vor","delay-in-days":236,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1074\/jbc.ra120.012665","type":"journal-article","created":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T23:45:10Z","timestamp":1584402310000},"page":"5577-5587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Determination of globotriaosylceramide analogs in the organs of a mouse model of Fabry disease"],"prefix":"10.1016","volume":"295","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1377-7797","authenticated-orcid":false,"given":"Satoshi","family":"Ishii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsumi","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomu","family":"Okino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.RA120.012665_bib1","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","article-title":"Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency","volume":"276","author":"Brady","year":"1967","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.RA120.012665_bib2","series-title":"\u03b1-Galactosidase A deficiency: Fabry disease","first-page":"3733","author":"Desnick","year":"2001"},{"key":"10.1074\/jbc.RA120.012665_bib3","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jmg.38.11.750","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males","volume":"38","author":"MacDermot","year":"2001","journal-title":"J. Med. Genet"},{"key":"10.1074\/jbc.RA120.012665_bib4","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1073\/pnas.94.6.2540","article-title":"\u03b1-galactosidase A deficient mice: a model of Fabry disease","volume":"94","author":"Ohshima","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA120.012665_bib5","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1089\/10430349950017671","article-title":"Correction of enzymatic and lysosomal storage defects in Fabry mice by adenovirus-mediated gene transfer","volume":"10","author":"Ziegler","year":"1999","journal-title":"Hum. Gene Ther"},{"key":"10.1074\/jbc.RA120.012665_bib6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1042\/BJ20130825","article-title":"A symptomatic Fabry disease mouse model generated by inducing globotriaosylceramide synthesis","volume":"456","author":"Taguchi","year":"2013","journal-title":"Biochem. J"},{"key":"10.1074\/jbc.RA120.012665_bib7","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1096\/fj.201701374R","article-title":"Medullary thick ascending limb impairment in the GlatmTg(CAG-A4GALT) Fabry model mice","volume":"32","author":"Maruyama","year":"2018","journal-title":"FASEB J"},{"key":"10.1074\/jbc.RA120.012665_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human \u03b1-galactosidase A replacement therapy in Fabry's disease","volume":"345","author":"Eng","year":"2001","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.RA120.012665_bib9","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"10.1074\/jbc.RA120.012665_bib10","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s40265-016-0607-y","article-title":"Migalastat: first global approval","volume":"76","author":"Markham","year":"2016","journal-title":"Drugs"},{"key":"10.1074\/jbc.RA120.012665_bib11","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1093\/hmg\/ddy248","article-title":"Glucosylceramide synthase inhibition with lucerastat lowers globotriaosylceramide and lysosome staining in cultured fibroblasts from Fabry patients with different mutation types","volume":"27","author":"Welford","year":"2018","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.RA120.012665_bib12","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1046\/j.1523-1755.2002.00675.x","article-title":"Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy","volume":"62","author":"Thurberg","year":"2002","journal-title":"Kidney Int"},{"key":"10.1074\/jbc.RA120.012665_bib13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1086\/422366","article-title":"Long-term safety and efficacy of enzyme replacement therapy for Fabry disease","volume":"75","author":"Wilcox","year":"2004","journal-title":"Am. J. Hum. Genet"},{"key":"10.1074\/jbc.RA120.012665_bib14","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","article-title":"Elevated globotriaosylsphingosine is a hallmark of Fabry disease","volume":"105","author":"Aerts","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA120.012665_bib15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbadis.2010.09.007","article-title":"Reduction of elevated plasma globotriaosylsphingosine in patients with classic Fabry disease following enzyme replacement therapy","volume":"1812","author":"van Breemen","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.RA120.012665_bib16","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1021\/ac303033v","article-title":"Multiplex analysis of novel urinary lyso-Gb3-related biomarkers for Fabry disease by tandem mass spectrometry","volume":"85","author":"Lavoie","year":"2013","journal-title":"Anal. Chem"},{"key":"10.1074\/jbc.RA120.012665_bib17","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1021\/ac404000d","article-title":"Multiplex tandem mass spectrometry analysis of novel plasma lyso-Gb3-related analogues in Fabry disease","volume":"86","author":"Boutin","year":"2014","journal-title":"Anal. Chem"},{"key":"10.1074\/jbc.RA120.012665_bib18","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.2174\/092986712800784739","article-title":"Novel Gb3 isoforms detected in urine of Fabry disease patients: a metabolomic study","volume":"19","author":"Auray-Blais","year":"2012","journal-title":"Curr. Med. Chem"},{"key":"10.1074\/jbc.RA120.012665_bib19","doi-asserted-by":"crossref","first-page":"9039","DOI":"10.1021\/ac401542k","article-title":"A metabolomic study to identify new globotriaosylceramide-related biomarkers in the plasma of Fabry disease patients","volume":"85","author":"Manwaring","year":"2013","journal-title":"Anal. Chem"},{"key":"10.1074\/jbc.RA120.012665_bib20","doi-asserted-by":"crossref","first-page":"13112","DOI":"10.1016\/S0021-9258(18)43014-1","article-title":"Testosterone effects on the induction and urinary excretion of mouse kidney glycosphingolipids associated with lysosomes","volume":"256","author":"McCluer","year":"1981","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA120.012665_bib21","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1124\/jpet.108.149054","article-title":"Preclinical efficacy and safety of 1-deoxygalactonojirimycin in mice for Fabry disease","volume":"328","author":"Ishii","year":"2009","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1074\/jbc.RA120.012665_bib22","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1006\/abio.1998.2966","article-title":"Quantitative determination of globotriaosylceramide by immunodetection of glycolipid-bound recombinant verotoxin B subunit","volume":"267","author":"Zeidner","year":"1999","journal-title":"Anal. Biochem"},{"key":"10.1074\/jbc.RA120.012665_bib23","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1248\/cpb.54.522","article-title":"Histidine-tagged shiga toxin B subunit binding assay: simple and specific determination of gb3 content in mammalian cells","volume":"54","author":"Shin","year":"2006","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1074\/jbc.RA120.012665_bib24","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.cca.2013.09.008","article-title":"Plasma globotriaosylsphingosine (lysoGb3) could be a biomarker for Fabry disease with a Chinese hotspot late-onset mutation (IVS4+919G>A)","volume":"426","author":"Liao","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1074\/jbc.RA120.012665_bib25","doi-asserted-by":"crossref","first-page":"17300","DOI":"10.1074\/jbc.M110688200","article-title":"Molecular cloning and characterization of sphingolipid ceramide N-deacylase from a marine bacterium, Shewanella alga G8","volume":"277","author":"Furusato","year":"2002","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA120.012665_bib26","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1194\/jlr.D061176","article-title":"A facile method for controlling the reaction equilibrium of sphingolipid ceramide N-deacylase for lyso-glycosphingolipid production","volume":"56","author":"Huang","year":"2015","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.RA120.012665_bib27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/gim.2018.31","article-title":"Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis","volume":"21","author":"Maruyama","year":"2019","journal-title":"Genet. Med"},{"key":"10.1074\/jbc.RA120.012665_bib28","doi-asserted-by":"crossref","first-page":"e0144958","DOI":"10.1371\/journal.pone.0144958","article-title":"Distributions of globotriaosylceramide isoforms, and globotriaosylsphingosine and its analogues in an \u03b1-galactosidase A knockout mouse, a model of Fabry disease","volume":"10","author":"Sueoka","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.RA120.012665_bib29","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.4155\/bio-2016-0116","article-title":"Relative distribution of Gb3 isoforms\/analogs in NOD\/SCID\/Fabry mice tissues determined by tandem mass spectrometry","volume":"8","author":"Proven\u00e7al","year":"2016","journal-title":"Bioanalysis"},{"key":"10.1074\/jbc.RA120.012665_bib30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jb\/mvq125","article-title":"Increased globotriaosylceramide levels in a transgenic mouse expressing human \u03b11,4-galactosyltransferase and a mouse model for treating Fabry disease","volume":"149","author":"Shiozuka","year":"2011","journal-title":"J. Biochem"},{"key":"10.1074\/jbc.RA120.012665_bib31","doi-asserted-by":"crossref","first-page":"E69","DOI":"10.3390\/pharmaceutics10020069","article-title":"A liquid chromatography-quadrupole-time-of-flight mass spectrometric assay for the quantification of Fabry disease biomarker globotriaosylceramide (GB3) in Fabry model mouse","volume":"10","author":"Shin","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1074\/jbc.RA120.012665_bib32","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ymgme.2016.10.003","article-title":"Differences in cleavage of globotriaosylceramide and its derivatives accumulated in organs of young Fabry mice following enzyme replacement therapy","volume":"120","author":"Kodama","year":"2017","journal-title":"Mol. Genet. Metab"},{"key":"10.1074\/jbc.RA120.012665_bib33","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1194\/jlr.D800051-JLR200","article-title":"Quantitative analysis of sphingolipids for lipidomics using triple quadrupole and quadrupole linear ion trap mass spectrometers","volume":"50","author":"Shaner","year":"2009","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.RA120.012665_bib34","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0005-2760(84)90092-4","article-title":"Biosynthesis of 4D-hydroxysphinganine by the rat: en bloc incorporation of the sphinganine carbon backbone","volume":"795","author":"Crossman","year":"1984","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.RA120.012665_bib35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0014-5793(04)00274-1","article-title":"Identification of the human sphingolipid C4-hydroxylase, hDES2, and its up-regulation during keratinocyte differentiation","volume":"563","author":"Mizutani","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1074\/jbc.RA120.012665_bib36","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1373\/clinchem.2006.079012","article-title":"HPLC for simultaneous quantification of total ceramide, glucosylceramide, and ceramide trihexoside concentrations in plasma","volume":"53","author":"Groener","year":"2007","journal-title":"Clin. Chem"},{"key":"10.1074\/jbc.RA120.012665_bib37","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jchromb.2011.11.020","article-title":"Quantification of the Fabry marker lysoGb3 in human plasma by tandem mass spectrometry","volume":"883","author":"Kr\u00fcger","year":"2012","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci"},{"key":"10.1074\/jbc.RA120.012665_bib38","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2215\/CJN.08780812","article-title":"Screening of male dialysis patients for Fabry disease by plasma globotriaosylsphingosine","volume":"8","author":"Maruyama","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925817502896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925817502896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.RA120.012665","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T17:13:02Z","timestamp":1640970782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925817502896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":38,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0021925817502896"],"URL":"https:\/\/doi.org\/10.1074\/jbc.ra120.012665","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determination of globotriaosylceramide analogs in the organs of a mouse model of Fabry disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.RA120.012665","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Ishii et al.","name":"copyright","label":"Copyright"}]}}